| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |